DOUTOR NICHIRES Holdings Co., Ltd.
Notice Regarding Revision of Dividend Forecast
Revised the dividend forecast for the fiscal year ending February 2026 to an annual dividend of 56 yen. The year-end dividend was increased by 2 yen from 27 yen to 29 yen, representing a 6 yen increase compared to the previous fiscal year.
Key Figures
- Annual Dividend Forecast: 56 yen (6 yen increase YoY)
- Year-end Dividend Forecast: 29 yen (2 yen increase from previous forecast of 27 yen)
- Second Quarter-end Dividend Result: 27 yen (Increase from 23 yen in previous year)
AI要約
Reason for Revision of Dividend Forecast
Doutor Nireos Holdings Co., Ltd. positions returning profits to shareholders as its highest priority. Although there were increases in raw material costs and selling, general and administrative expenses during the fiscal year ending February 2026, sales steadily grew with a recovery trend in the second half, resulting in performance nearly in line with plans. Based on this, and following the basic policy targeting a payout ratio of 30% to 40%, the year-end dividend has been increased from 27 yen to 29 yen, and the annual dividend forecast has been revised to 56 yen.
Details and Impact of Dividend Revision
With this dividend forecast revision, the annual dividend increases by 6 yen from 50 yen in the previous fiscal year to 56 yen. The second quarter-end dividend was 27 yen, up from 23 yen in the previous fiscal year. Shareholders can expect enhanced profit returns through this dividend increase, reflecting a continuation of the dividend policy aligned with the recovery trend in performance. Details regarding number of outstanding shares and use of funds are not disclosed.
